ApprovalTrail

Approval · Notice of Compliance 3547 · 2003

IVADAL: Notice of Compliance 3547

Issued September 12, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3547
Date
September 12, 2003
Company
Sanofi-Synthelabo Canada Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer and product name change
Therapeutic class
Hypnotic agent

Products in this notice

BrandDINStatus today
IVADAL02205971Cancelled Pre Market
IVADAL02205998Cancelled Pre Market

Medicinal ingredients